Alterity Therapeutics Limited (PRNAF) .
本页证实的标准:
SharesGrow 综合评分： 46/100 其中 2/7 项标准通过。
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-0.01 | $142.66K | $-7.73M | -5418.3% |
| 2017 | $-0.01 | $132.4K | $-7.54M | -5696.6% |
| 2018 | $-0.02 | $201.17K | $-8.27M | -4108.8% |
| 2019 | $-0.02 | $4.95M | $-12.34M | -249.2% |
| 2020 | $-0.02 | $0.00 | $-13.46M | - |
| 2021 | $-0.01 | $4.34M | $-15.31M | -352.8% |
| 2022 | $-0.01 | $5.12M | $-12.85M | -250.7% |
| 2023 | $-0.01 | $3.92M | $-13.81M | -352.5% |
| 2024 | $-0.01 | $4.02M | $-19.12M | -475.8% |
| 2025 | $0.00 | $5.44M | $-12.15M | -223.4% |
